Loading clinical trials...
Loading clinical trials...
A Pilot Study of Enasidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH2: A Decentralized Trial
Conditions
Interventions
Enasidenib
Locations
1
United States
Washington University School of Medicine
St Louis, Missouri, United States
Start Date
October 10, 2024
Primary Completion Date
January 31, 2028
Completion Date
February 28, 2029
Last Updated
February 11, 2026
NCT06063486
NCT06295965
NCT06788691
NCT06802146
NCT05030441
NCT07435636
Lead Sponsor
Washington University School of Medicine
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions